Phase II Gemcitabine + Fractionated Stereotactic Radiotherapy for Unresectable Pancreatic Adenocarcinoma
Clinical trial NCT01146054 · COMPLETED
Trial details
- NCT number
- NCT01146054
- Sponsor
- Stanford University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-10-01
- Primary completion
- 2013-10-01
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.